1 recruiting, 1 terminated, 1 unknown. 1 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Terminated 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Trimipramine: new trials by email Literature Review of Trimipramine trials Research Report on Trimipramine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a Phase 2 Trial Trimipramine, Cohort 1: Atezolizumab, Bevacizumab - Glioblastoma, Recurrence Tumor | Phase 2 | Recruiting | Centre Hospitalier Universitaire Vaudois | 59 | 2025-11-03 | 2026-02-13 |
| Pharmacovigilance in Gerontopsychiatric Patients Phenobarbital, Phenytoin, Carbamazepine - Dementia, Depression | Phase 3 | Terminated | Hannover Medical School | 407 | 2015-01-01 | 2018-02-28 |
| Optimizing Antidepressant Treatment by Genotype-dependent Adjustment of Medication According to the ABCB1 Gene Paroxetine, Sertraline, Citalopram - Major Depression | Phase 4 | Unknown | HolsboerMaschmeyer NeuroChemie GmbH | 80 | 2011-09-01 | 2014-09-12 |
Depression (2) · Anxiety Disorders (1) · Dementia (1) · Depressive Disorder, Major (1) · Glioblastoma (1) · Mood Disorders (1) · Psychophysiologic Disorders (1) · Recurrence (1) · Schizophrenia (1)
Centre Hospitalier Universitaire Vaudois (1) · Hannover Medical School (1) · HolsboerMaschmeyer NeuroChemie GmbH (1)
Germany (2) · Switzerland (1)
Florian Holsboer, MD, PHD (1) · Helge Frieling, Prof., MD (1)